DPP4 and neoplasm: In the absence of host CD26, the Th17 cells drastically decreased tumor burden and increased survival (8/10 responders; survival of WT vs CD26-/- p=0.016, WT+sitagliptin vs. CD26-/- p=0.008, Mantel-Cox Logrank test).